refractory plasma cell neoplasm

Known as: Refractory Multiple Myeloma, Refractory Plasma Cell Myeloma, plasma cell neoplasm, refractory 
A plasma cell neoplasm that is resistant to treatment.
National Institutes of Health

Topic mentions per year

Topic mentions per year

1990-2017
0102019902017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
PURPOSE The onset of drug resistance is a major cause of treatment failure in multiple myeloma. Although increasing evidence is… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2016
2016
PURPOSE Evaluate the safety, pharmacokinetic profile, pharmacodynamic effects, and antitumor activity of the first-in-class… (More)
Is this relevant?
2016
2016
PURPOSE Tabalumab, a human mAb that neutralizes B-cell-activating factor (BAFF), demonstrated antitumor activity in xenograft… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2015
Highly Cited
2015
BACKGROUND Elotuzumab, an immunostimulatory monoclonal antibody targeting signaling lymphocytic activation molecule F7 (SLAMF7… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
Is this relevant?
2015
2015
This single institution, open label Phase I-II dose escalation trial evaluated the safety and efficacy of the combination of… (More)
Is this relevant?
2015
2015
CD38 is a type II transmembrane glycoprotein that is highly expressed in multiple myeloma and is a promising target for… (More)
  • figure 1
Is this relevant?
2015
2015
BACKGROUND Health-related quality of life (HRQoL) is an important element for consideration in treatment decisions in patients… (More)
Is this relevant?
2013
2013
BACKGROUND Newer systemic therapies have significantly advanced the treatment of multiple myeloma, but additional agents are… (More)
Is this relevant?
2013
2013
Salvage therapy of elderly patients with advanced, relapsed and refractory multiple myeloma (MM) is often limited by poor marrow… (More)
  • table 1
  • figure 1
  • table 2
Is this relevant?
Highly Cited
2007
Highly Cited
2007
MV-NIS is an oncolytic measles virus encoding the human thyroidal sodium iodide symporter (NIS). Here, we report the results of… (More)
Is this relevant?